insights_auto
Why is NWBO up 2,79%?
Dive Deeperchevron_right
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
US$0,17
arrow_upward
+2,79%(+0,0045) 1D
13 ຕ.ລ., 13 ໂມງ 34 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NWBO...
Open
US$0,16
High
US$0,17
Low
US$0,16
Mkt. cap
287,57 ລ້ານ
Avg. vol.
4,28 ລ້ານ
Volume
4,37 ລ້ານ
52-wk high
US$0,34
52-wk low
US$0,14
EPS
US$-0,03
Beta
-0,62
Shares outstanding
1,71 ຕື້
No. of employees
105
Open
US$0,16
High
US$0,17
Low
US$0,16
Mkt. cap
287,57 ລ້ານ
Avg. vol.
4,28 ລ້ານ
Volume
4,37 ລ້ານ
52-wk high
US$0,34
52-wk low
US$0,14
EPS
US$-0,03
Beta
-0,62
Shares outstanding
1,71 ຕື້
No. of employees
105
News stories
From web sources and news partners
The Seattle Times
·
11 ນາທີກ່ອນ
The first big batch of US profit reports for the summer has Wall Street mixed
Yahoo Finance
·
26 ນາທີກ່ອນ
A Look Back at Digital Media & Content Platforms Stocks’ Q2 Earnings: People (NASDAQ:PPLI) Vs The Rest Of The Pack
The Motley Fool
·
43 ນາທີກ່ອນ
Tech Stocks Are Crushing the Market, but There's a Sneaky (and Dangerous) Risk for S&P 500 Investors
Bloomberg.com
·
3 ຊົ່ວໂມງກ່ອນ
S&P 500 Record Rally Meets Risk of Peaking Earnings Growth
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc